Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Melanie Ruf, Holger Moch & Peter Schraml. (2015) Interaction of tumor cells with infiltrating lymphocytes via CD70 and CD27 in clear cell renal cell carcinoma. OncoImmunology 4:12.
Read now
Read now
Alex Klarenbeek, Khalil El Mazouari, Aline Desmyter, Christophe Blanchetot, Anna Hultberg, Natalie de Jonge, Rob C Roovers, Christian Cambillau, Sylvia Spinelli, Jurgen Del-Favero, Theo Verrips, Hans J de Haard & Ikbel Achour. (2015) Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform. mAbs 7:4, pages 693-706.
Read now
Read now
Naifu Liu, Xiugui Sheng, Yi Liu, Xiaoling Zhang & Jinming Yu. (2013) Increased CD70 expression is associated with clinical resistance to cisplatin-based chemotherapy and poor survival in advanced ovarian carcinomas. OncoTargets and Therapy 6, pages 615-619.
Read now
Read now
Irene Meester & Juan Manuel Solis-Soto. (2009) Cytokines: monitors of disease severity for the clinic. Expert Opinion on Medical Diagnostics 3:2, pages 143-155.
Read now
Read now
Articles from other publishers (43)
Jonathan Charles, Andrea Vrionis, Arian Mansur, Trevor Mathias, Jamil Shaikh, Aaron Ciner, Yixing Jiang & Nariman Nezami. (2023) Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies. Cancers 15:9, pages 2624.
Crossref
Crossref
Takayuki Ikezoe, Kensuke Usuki, Kensuke Aida, Tomoyoshi Hatayama, Toru Shirahase & Takahiro Yamauchi. (2022) Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatment. Cancer Science 114:3, pages 1037-1044.
Crossref
Crossref
Siler H. Panowski, Surabhi Srinivasan, Nguyen Tan, Silvia K. Tacheva-Grigorova, Bryan Smith, Yvonne S.L. Mak, Hongxiu Ning, Jonathan Villanueva, Dinali Wijewarnasuriya, Shanshan Lang, Zea Melton, Adit Ghosh, Mathilde Dusseaux, Roman Galetto, Jonathan R. Heyen, Tao Sai, Thomas Van Blarcom, Javier Chaparro-Riggers & Barbra J. Sasu. (2022) Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma. Cancer Research 82:14, pages 2610-2624.
Crossref
Crossref
Marcin Kleibert, Miłosz Majka, Klaudia Łakomska & Małgorzata Czystowska-Kuźmicz. (2022) Extracellular Vesicles—A New Potential Player in the Immunology of Renal Cell Carcinoma. Journal of Personalized Medicine 12:5, pages 772.
Crossref
Crossref
Mathieu Seyfrid, William Thomas Maich, Muhammad Vaseem Shaikh, Nazanin Tatari, Deepak Upreti, Deween Piyasena, Minomi Subapanditha, Neil Savage, Dillon McKenna, Nicholas Mikolajewicz, Hong Han, Chirayu Chokshi, Laura Kuhlmann, Amanda Khoo, Sabra Khalid Salim, Blessing Archibong-Bassey, William Gwynne, Kevin Brown, Nadeem Murtaza, David Bakhshinyan, Parvez Vora, Chitra Venugopal, Jason Moffat, Thomas Kislinger & Sheila Singh. (2022) CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment. Journal for ImmunoTherapy of Cancer 10:1, pages e003289.
Crossref
Crossref
Astrid De Meulenaere, Tijl Vermassen, David Creytens, Stijn De Keukeleire, Tim Delahaye, Philippe Deron, Fréderic Duprez, Samson Fung, Patrick Pauwels, Liesbeth Ferdinande & Sylvie Rottey. (2021) An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma. Clinical and Translational Science 14:6, pages 2300-2313.
Crossref
Crossref
Mayu Shiomi, Shinya Matsuzaki, Satoshi Serada, Koji Matsuo, Chihiro Mizuta‐Odani, Mariko Jitsumori, Ruriko Nakae, Satoko Matsuzaki, Satoshi Nakagawa, Kosuke Hiramatsu, Ai Miyoshi, Eiji Kobayashi, Toshihiro Kimura, Yutaka Ueda, Kiyoshi Yoshino, Tetsuji Naka & Tadashi Kimura. (2021) CD70 antibody‐drug conjugate: A potential novel therapeutic agent for ovarian cancer. Cancer Science 112:9, pages 3655-3668.
Crossref
Crossref
Tim Sauer, Kathan ParikhSandhya SharmaBilal Omer, David SedloevQian ChenLinus Angenendt, Christoph Schliemann, Michael SchmittCarsten Müller-TidowStephen Gottschalk & Cliona M. Rooney. (2021) CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity. Blood 138:4, pages 318-330.
Crossref
Crossref
Ruriko Nakae, Shinya Matsuzaki, Satoshi Serada, Koji Matsuo, Mayu Shiomi, Kazuaki Sato, Yoshikazu Nagase, Satoko Matsuzaki, Satoshi Nakagawa, Kosuke Hiramatsu, Akiko Okazawa, Toshihiro Kimura, Tomomi Egawa-Takata, Eiji Kobayashi, Yutaka Ueda, Kiyoshi Yoshino, Tetsuji Naka & Tadashi Kimura. (2021) CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma. American Journal of Obstetrics and Gynecology 224:2, pages 197.e1-197.e23.
Crossref
Crossref
Naidu S. Chowdari, Yong Zhang, Ivar McDonald, Walter Johnson, David R. Langley, Prasanna Sivaprakasam, Robert Mate, Tram Huynh, Srikanth Kotapati, Madhura Deshpande, Chin Pan, Daniel Menezes, Yichong Wang, Chetana Rao, Ganapathy Sarma, Bethanne M. Warrack, Vangipuram S. Rangan, Sung Mei-Chen, Pina Cardarelli, Shrikant Deshpande, David Passmore, Richard Rampulla, Arvind Mathur, Robert Borzilleri, Arvind Rajpal, Gregory Vite & Sanjeev Gangwar. (2020) Design, Synthesis, and Structure–Activity Relationships of Novel Tetrahydroisoquinolino Benzodiazepine Dimer Antitumor Agents and Their Application in Antibody–Drug Conjugates. Journal of Medicinal Chemistry 63:22, pages 13913-13950.
Crossref
Crossref
Di Wang, Juan Du, Yangzi Song, Beibei Wang, Rui Song, Yu Hao, Yongqin Zeng, Jiang Xiao, Hong Zheng, Hui Zeng, Hongxin Zhao & Yaxian Kong. (2020) CD70 contributes to age-associated T cell defects and overwhelming inflammatory responses. Aging 12:12, pages 12032-12050.
Crossref
Crossref
Edward Abadir, Robin E. Gasiorowski, Pablo A. Silveira, Stephen Larsen & Georgina J. Clark. (2020) Is Hematopoietic Stem Cell Transplantation Required to Unleash the Full Potential of Immunotherapy in Acute Myeloid Leukemia?. Journal of Clinical Medicine 9:2, pages 554.
Crossref
Crossref
Hao Wang, Gurbakhash Kaur, Alexander I. Sankin, Fuxiang Chen, Fangxia Guan & Xingxing Zang. (2019) Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies. Journal of Hematology & Oncology 12:1.
Crossref
Crossref
Naidu S. Chowdari, Chin Pan, Chetana Rao, David R. Langley, Prasanna Sivaprakasam, Bilal Sufi, Daniel Derwin, Yichong Wang, Eilene Kwok, David Passmore, Vangipuram S. Rangan, Shrikant Deshpande, Pina Cardarelli, Gregory Vite & Sanjeev Gangwar. (2019) Uncialamycin as a novel payload for antibody drug conjugate (ADC) based targeted cancer therapy. Bioorganic & Medicinal Chemistry Letters 29:3, pages 466-470.
Crossref
Crossref
Rachel E. O’Neill & Xuefang Cao. 2019. Immunotherapy of Cancer. Immunotherapy of Cancer
145
194
.
Li Liu, Bo Yin, Zhu Yi, XiuJuan Liu, ZhiQian Hu, WenChao Gao, HaiWen Yu & QingQuan Li. (2018) Breast cancer stem cells characterized by CD70 expression preferentially metastasize to the lungs. Breast Cancer 25:6, pages 706-716.
Crossref
Crossref
Shojiro Kitajima, Kian Leong Lee, Masaki Fujioka, Wendi Sun, Jia You, Grace Sushin Chia, Hideki Wanibuchi, Shuhei Tomita, Marito Araki, Hiroyuki Kato & Lorenz Poellinger. (2018) Hypoxia-inducible factor-2 alpha up-regulates CD70 under hypoxia and enhances anchorage-independent growth and aggressiveness in cancer cells. Oncotarget 9:27, pages 19123-19135.
Crossref
Crossref
Philippe Aftimos, Christian Rolfo, Sylvie Rottey, Fritz Offner, Dominique Bron, Marie Maerevoet, Jean-Charles Soria, Mahan Moshir, Torsten Dreier, Luc Van Rompaey, Jean-Marie Michot, Karen Silence, Anna Hultberg, Domenica Gandini, Hans de Haard, Vincent Ribrag, Marc Peeters, Alain Thibault, Nicolas Leupin & Ahmad Awada. (2017) Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies. Clinical Cancer Research 23:21, pages 6411-6420.
Crossref
Crossref
Klaus LeyNorbert GerdesHolger Winkels. (2017) ATVB Distinguished Scientist Award. Arteriosclerosis, Thrombosis, and Vascular Biology 37:5, pages 764-777.
Crossref
Crossref
Carsten Riether, Christian M. Schürch, Elias D. Bührer, Magdalena Hinterbrandner, Anne-Laure Huguenin, Sabine Hoepner, Inti Zlobec, Thomas Pabst, Ramin Radpour & Adrian F. Ochsenbein. (2017) CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia. Journal of Experimental Medicine 214:2, pages 359-380.
Crossref
Crossref
Emma J Grant, Simone Nüssing, Sneha Sant, E Bridie Clemens & Katherine Kedzierska. (2017) The role of CD27 in anti-viral T-cell immunity. Current Opinion in Virology 22, pages 77-88.
Crossref
Crossref
Yu-Jie Wang, Yu-Yan Li, Xiao-Yu Liu, Xiao-Ling Lu, Xin Cao & Bing-Hua Jiao. (2017) Marine Antibody–Drug Conjugates: Design Strategies and Research Progress. Marine Drugs 15:1, pages 18.
Crossref
Crossref
Holger Winkels, Svenja Meiler, Esther Smeets, Dirk Lievens, David Engel, Charlotte Spitz, Christina Bürger, Petteri Rinne, Linda Beckers, Angelika Dandl, Sigrid Reim, Maiwand Ahmadsei, Jan Van den Bossche, Lesca M. Holdt, Remco T. A. Megens, Martin M. Schmitt, Menno de Winther, Eric A. Biessen, Jannie Borst, Alexander Faussner, Christian Weber, Esther Lutgens & Norbert Gerdes. (2017) CD70 limits atherosclerosis and promotes macrophage function. Thrombosis and Haemostasis 117:01, pages 164-175.
Crossref
Crossref
Christine Pich, Iotefa Teiti, Guillaume Sarrabayrouse, Franck Gallardo, Rémi Gence & Anne-Françoise Tilkin-Mariamé. (2016) Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity. PLOS ONE 11:2, pages e0148095.
Crossref
Crossref
Christine Pich, Guillaume Sarrabayrouse, Iotefa Teiti, Bernard Mariamé, Philippe Rochaix, Laurence Lamant, Gilles Favre, Véronique Maisongrosse & Anne-Françoise Tilkin-Mariamé. (2015) Melanoma-expressed CD70 is involved in invasion and metastasis. British Journal of Cancer 114:1, pages 63-70.
Crossref
Crossref
Taofeek Kunle Owonikoko, Arif Hussain, Walter Michael Stadler, David C. Smith, Harriet Kluger, Ana M. Molina, Parul Gulati, Aadhar Shah, Christoph Matthias Ahlers, Pina M. Cardarelli & Lewis J. Cohen. (2015) First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70. Cancer Chemotherapy and Pharmacology 77:1, pages 155-162.
Crossref
Crossref
Kathleen M. Mahoney, Paul D. Rennert & Gordon J. Freeman. (2015) Combination cancer immunotherapy and new immunomodulatory targets. Nature Reviews Drug Discovery 14:8, pages 561-584.
Crossref
Crossref
Carsten RietherChristian M. SchürchChristoph FluryMagdalena HinterbrandnerLinda DrückAnne-Laure HugueninGabriela M. BaerlocherRamin RadpourAdrian F. Ochsenbein. (2015) Tyrosine kinase inhibitor–induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling. Science Translational Medicine 7:298.
Crossref
Crossref
Melanie Ruf, Christiane Mittmann, Anna M. Nowicka, Arndt Hartmann, Thomas Hermanns, Cédric Poyet, Maries van den Broek, Tullio Sulser, Holger Moch & Peter Schraml. (2015) pVHL/HIF-Regulated CD70 Expression Is Associated with Infiltration of CD27+ Lymphocytes and Increased Serum Levels of Soluble CD27 in Clear Cell Renal Cell Carcinoma. Clinical Cancer Research 21:4, pages 889-898.
Crossref
Crossref
Nizar M. Tannir, Andres Forero-Torres, Radhakrishnan Ramchandren, Sumanta K. Pal, Stephen M. Ansell, Jeffrey R. Infante, Sven de Vos, Paul A. Hamlin, Stella K. Kim, Nancy C. Whiting, Elaina M. Gartner, Baiteng Zhao & John A. Thompson. (2014) Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma. Investigational New Drugs 32:6, pages 1246-1257.
Crossref
Crossref
J Trebing, M El-Mesery, V Schäfer, D Weisenberger, D Siegmund, K Silence & H Wajant. (2014) CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants. Cell Death & Disease 5:1, pages e1035-e1035.
Crossref
Crossref
Scott C. Jeffrey, Patrick J. Burke, Robert P. Lyon, David W. Meyer, Django Sussman, Martha Anderson, Joshua H. Hunter, Chris I. Leiske, Jamie B. Miyamoto, Nicole D. Nicholas, Nicole M. Okeley, Russell J. Sanderson, Ivan J. Stone, Weiping Zeng, Stephen J. Gregson, Luke Masterson, Arnaud C. Tiberghien, Philip W. Howard, David E. Thurston, Che-Leung Law & Peter D. Senter. (2013) A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology. Bioconjugate Chemistry 24:7, pages 1256-1263.
Crossref
Crossref
Edwin Bremer. (2013) Targeting of the Tumor Necrosis Factor Receptor Superfamily for Cancer Immunotherapy. ISRN Oncology 2013, pages 1-25.
Crossref
Crossref
Kazumi Yoshino, Kan Kishibe, Toshihiro Nagato, Seigo Ueda, Yuki Komabayashi, Miki Takahara & Yasuaki Harabuchi. (2012)
Expression of
CD
70 in nasal natural killer/
T
cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble
CD
27
. British Journal of Haematology 160:3, pages 331-342.
Crossref
Crossref
Lucia B. Jilaveanu, Joshua Sznol, Saadia A. Aziz, Dylan Duchen, Harriet M. Kluger & Robert L. Camp. (2012) CD70 expression patterns in renal cell carcinoma. Human Pathology 43:9, pages 1394-1399.
Crossref
Crossref
Lin Liu, Meili Sun & Zhehai Wang. (2012) Adoptive T-cell therapy of B-cell malignancies: Conventional and physiological chimeric antigen receptors. Cancer Letters 316:1, pages 1-5.
Crossref
Crossref
Hina Shariff, Roseanna E. Greenlaw, Lucy Meader, Nicola Gardner, Hideo Yagita, Marco Coccia, Nizam Mamode & Stipo Jurcevic. (2011) Role of the Fc Region in CD70-Specific Antibody Effects on Cardiac Transplant Survival. Transplantation 92:11, pages 1194-1201.
Crossref
Crossref
Beverly A. Teicher & Ravi V.J. Chari. (2011) Antibody Conjugate Therapeutics: Challenges and Potential. Clinical Cancer Research 17:20, pages 6389-6397.
Crossref
Crossref
Carol A. Vater & Victor S. Goldmacher. 2010. Macromolecular Anticancer Therapeutics. Macromolecular Anticancer Therapeutics
331
369
.
Ezogelin Oflazoglu, Tamar E. Boursalian, Weiping Zeng, Ana C. Edwards, Steve Duniho, Julie A. McEarchern, Che-Leung Law, Hans-Peter Gerber & Iqbal S. Grewal. (2009) Blocking of CD27-CD70 Pathway by Anti-CD70 Antibody Ameliorates Joint Disease in Murine Collagen-Induced Arthritis. The Journal of Immunology 183:6, pages 3770-3777.
Crossref
Crossref
Monika Manocha, Rietdijk Svend, Amale Laouar, Gongxian Liao, Atul Bhan, Jannine Borst, Cox Terhorst & N. Manjunath. (2009) Blocking CD27-CD70 Costimulatory Pathway Suppresses Experimental Colitis. The Journal of Immunology 183:1, pages 270-276.
Crossref
Crossref
Martijn A. Nolte, Ronald W. van Olffen, Klaas P. J. M. van Gisbergen & René A. W. van Lier. (2009) Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunological Reviews 229:1, pages 216-231.
Crossref
Crossref
Che-Leung Law, Julie A. McEarchern & Iqbal S. Grewal. (2009) Novel Antibody-Based Therapeutic Agents Targeting CD70: A Potential Approach for Treating Waldenström's Macroglobulinemia. Clinical Lymphoma and Myeloma 9:1, pages 90-93.
Crossref
Crossref